GSA Awards Leidos Healthcare Information Technology and Cybersecurity Contract
RESTON, Va., March 8, 2017 /PRNewswire/ -- Leidos (NYSE: LDOS), a global science and technology company, was awarded a prime contract by the General Services Administration (GSA) to provide healthcare information technology and a range of cybersecurity services through the GSA IT Schedule 70 vehicle. The multiple-award indefinite delivery/indefinite quantity contract has a period of performance through December 12, 2032, including all options. There is no dollar ceiling limit on this flexible contract vehicle. Leidos is one of 25 companies that have been authorized to provide services to the government under all four "highly adaptive" cybersecurity service special item numbers (SINs).
The GSA Schedule 70 is the largest, most widely used acquisition tool in the federal government and provides direct access to products, services, and solutions from more than 4,700 certified industry partners. Leidos has demonstrated experience in delivering high-quality healthcare IT and cybersecurity services to numerous federal, civil, and commercial customers. Under the contract modification, Leidos will offer support to government agencies through the health IT, penetration testing, incident response, cyber hunt and risk and vulnerability assessment SINS.
"The health IT and cybersecurity scope additions to our GSA IT 70 Schedule will allow for dynamic growth within those core Leidos markets," said Leidos Chief of Business Development & Strategy, Gerry Fasano. "This vehicle provides our customers with a quick way to meet their mission requirements and provides Leidos with a key contract vehicle to pursue important markets."
Leidos is a global science and technology solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 32,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $7.04 billion for the fiscal year ended December 30, 2016. For more information, visit www.Leidos.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended December 30, 2016, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.